دورية أكاديمية

Monovalent engagement of the BCR activates ovalbumin-specific transnuclear B cells

التفاصيل البيبلوغرافية
العنوان: Monovalent engagement of the BCR activates ovalbumin-specific transnuclear B cells
المؤلفون: Avalos, Ana M., Bilate, Angelina M., Witte, Martin D., Tai, Albert K., He, Jiang, Frushicheva, Maria P., Thill, Peter Daniel, Meyer-Wentrup, Friederike, Theile, Christopher S., Chakraborty, Arup K., Zhuang, Xiaowei, Ploegh, Hidde
المساهمون: Massachusetts Institute of Technology. Institute for Medical Engineering & Science, Massachusetts Institute of Technology. Department of Biological Engineering, Massachusetts Institute of Technology. Department of Chemical Engineering, Massachusetts Institute of Technology. Department of Chemistry, Massachusetts Institute of Technology. Department of Physics, Ragon Institute of MGH, MIT and Harvard, Whitehead Institute for Biomedical Research, Frushicheva, Maria P., Thill, Peter Daniel, Chakraborty, Arup K., Ploegh, Hidde
المصدر: Rockefeller University Press
بيانات النشر: Rockefeller University Press
سنة النشر: 2013
المجموعة: DSpace@MIT (Massachusetts Institute of Technology)
الوصف: Valency requirements for B cell activation upon antigen encounter are poorly understood. OB1 transnuclear B cells express an IgG1 B cell receptor (BCR) specific for ovalbumin (OVA), the epitope of which can be mimicked using short synthetic peptides to allow antigen-specific engagement of the BCR. By altering length and valency of epitope-bearing synthetic peptides, we examined the properties of ligands required for optimal OB1 B cell activation. Monovalent engagement of the BCR with an epitope-bearing 17-mer synthetic peptide readily activated OB1 B cells. Dimers of the minimal peptide epitope oriented in an N to N configuration were more stimulatory than their C to C counterparts. Although shorter length correlated with less activation, a monomeric 8-mer peptide epitope behaved as a weak agonist that blocked responses to cell-bound peptide antigen, a blockade which could not be reversed by CD40 ligation. The 8-mer not only delivered a suboptimal signal, which blocked subsequent responses to OVA, anti-IgG, and anti-kappa, but also competed for binding with OVA. Our results show that fine-tuning of BCR-ligand recognition can lead to B cell nonresponsiveness, activation, or inhibition. ; National Institutes of Health (U.S.) (grant R01 AI087879) ; National Institutes of Health (U.S.) (grant R01 GM100518) ; National Institutes of Health (U.S.) (grant P01 AI091580) ; Netherlands Organization for Scientific Research
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
تدمد: 0022-1007
1540-9538
العلاقة: http://dx.doi.org/10.1084/jem.20131603Test; Journal of Experimental Medicine; http://hdl.handle.net/1721.1/90353Test; Avalos, A. M., A. M. Bilate, M. D. Witte, A. K. Tai, J. He, M. P. Frushicheva, P. D. Thill, et al. “Monovalent Engagement of the BCR Activates Ovalbumin-Specific Transnuclear B Cells.” Journal of Experimental Medicine 211, no. 2 (February 3, 2014): 365–379.; orcid:0000-0001-6259-8800; orcid:0000-0002-7487-8858; orcid:0000-0003-1268-9602; orcid:0000-0002-1090-6071
الإتاحة: https://doi.org/10.1084/jem.20131603Test
http://hdl.handle.net/1721.1/90353Test
حقوق: Creative Commons Attribution-Noncommercial-Share Alike ; http://creativecommons.org/licenses/by-nc-sa/3.0Test/
رقم الانضمام: edsbas.34D82AB7
قاعدة البيانات: BASE